Fusogenic liposomes that incorporate
Introduction
Gene therapy is the introduction of exogenous genetic material into cells or tissues in order to cure diseases or to improve their associated symptoms. Vectors that are utilized for gene transfer in gene therapy can be classified as either viral or non-viral. In general, viral vectors provide higher transfection efficiency, although they may induce adverse immune responses or provoke carcinogenesis. In contrast, cationic liposomes (the leading non-viral vector) are considered relatively safe for human applications (Choi et al., 2000) . However, they also have some shortcomings, which include a relatively low and transient gene expression.
A number of attempts have been made to increase the efficiency of the gene transfer by lipidic vectors. One such attempt was the development of virosomes, liposomal vesicles that incorporate viral fusogenic envelope proteins (Gitman et al., 1985) . Among the viral fusogenic proteins, the Sendai viral envelope proteins have been the most frequently utilized in the preparation of virosomes. The Sendai virus envelope contains two glycoproteins; hemagglutinin-neuraminidase (HN), as well as fusion (F) proteins that are anchored in the outer leaflet of the viral lipid bilayers. The F glycoprotein, which consists of two disulfide-linked polypeptides (F1 and F2), is required for viral entry into host cells, as well as for membrane fusion (Kumar et al., 1997; Kumar and Sarkar, 1996) . The HN glycoprotein mediates the attachment of the virus to the cell surface via sialic acid termini of glycoproteins or glycolipids, and may also actively participate in the process of virus-cell fusion (Nakanishi et al., 1982; Bagai et al., 1993) . This fusion process can be initiated directly at the cell surface under neutral pH conditions of the extracellular medium (Hsu et al., 1982) . Sendai virosomes have been assigned different names, depending on the procedure used for their preparation. For example, HVJ (hemagglutinating virus of Japan) liposomes can be prepared by incubation of the whole Sendai virus with liposomes that contain DNA (Dzau et al., 1996) . These HVJliposomes mediate efficient gene transfection, and their clinical applications in gene therapy have been evaluated (Tomita et al., 1996; Hirano et al., 1998) . HVJ-liposomes have some major shortcomings for clinical applications. These include variations in the gene expression, depending on the preparation conditions and viral contamination, which may induce adverse immune responses.
*To whom correspondence should be addressed. Tel: 82-33-760-2448; Fax: 82-33-763-5224 E-mail: yspark@dragon.yonsei.ac.kr Recently, we reported that the Sendai virosomes were an efficient vector for transferring the gene into 293 cells (Kim and Park, 2002) . Virosomal constituents, such as the lipid components and their molar ratios, and the concentrations of viral envelope proteins can dramatically affect the efficiency of the gene transfer that is mediated by Sendai virosomes (Kaneda et al., 1999; Ponimaskin et al., 2000) . In this study, we reconstituted Sendai envelopes in 3 different liposome formulations and investigated the effects of the different lipid compositions on the in vitro gene transfer and expression. The Sendai virosomes of varied lipid compositions were prepared by the quantitative addition of F-and HN-proteins by a detergent dialysis (Sechoy et al., 1986) . This study has delineated conditions for the optimization of the Sendai virosome-mediated gene transfection, which should prove useful for further in vivo, as well as clinical, applications. (Bibco, Grand Island, USA) . It was supplemented with 10% fetal bovine serum, 1 mM sodium bicarbonate, 50 µg/ml streptomycin, and 500 U/ml penicillin. 
Materials and Methods

Reagents
Virus preparation
Measurement of hemagglutinating activity of Sendai virus
Hemagglutination (HA) titration was conducted in 96 wellmicroplates with 0.3 ml round bottom cups. The virus suspension was serially diluted two fold in 100 µl of PBS, then 100 µl of 1% human erythrocytes in PBS was added to each well. After incubation at 4 o C for 1 h, the HA titer was recorded as the reciprocal of the highest dilution that showed positive HA, and was expressed as HA units (HAU) per milliliter.
Preparation and purification of F-proteins and HN-proteins
Sendai F-and HN-proteins were purified, as described by a previous report (Tomasi and Loyter, 1981) with minor modifications. A suspension of the Sendai virus in PBS was centrifuged at 100,000 g at 4 o C for 1 h. The pellet that was obtained was suspended in 2 ml of buffer B (150 mM NaCl, 10 mM TrisHCl, 2 mM Ca 
Electron microscopic observation of Sendai virosomes
The Sendai virosome suspensions were applied to 200 mesh copper grids (Tedpella Inc., Redding, USA) and stained with 5% uranyl acetate for 3-5 min. The stained virosomal vesicles on the grids were immediately examined in a Jeol 299EX-II electron microscope (Tokyo, Japan) at 80 KV and a 50,000-fold amplification.
Preparation of F/HN-virosomes containing the Luciferase gene
F/HN-virosomes were prepared by the detergent-dialysis method (Sechoy et al., 1986) . Ten mg of a lipid mixture of ePC: Chol:PS (4.8:2:1, molar ratio), ePC:Chol:PA (4.8:2:1, molar ratio) or an artificial Sendai viral envelope (ASVE, phospholipids [PA:PE:PS:PC SM = 4:30:18:20:28, molar ratio] cholesterol = 1:0.8, molar ratio) were dissolved in 1 ml of a chloroform/methanol mixture (2:1, v/v). The lipid mixture was dried to a thin film under nitrogen gas, then vacuum-desiccated for 1 h to remove residual traces of the organic solvent. Reporter gene DNA (luciferase, 500 µg) and 100 µg of F/HN-proteins were mixed with the lipid mixture by vortex mixing. An appropriate amount of octylglucoside was then added to the DNA/protein/lipid mixture, which resulted in a total of 0.5 ml of all the constituents that contained 50 mM OG. Sendai F/HN-virosomes were spontaneously prepared during dialysis to remove OG from the mixture solutions (Vainstein et al., 1984) . The mixture solutions were dialyzed against 1 l of PBS with two changes of medium for at least 24 h. Bio-Beads were added outside the bag in the buffered medium. The prepared virosomes were utilized for an in vitro gene transfection without removing the unencapsulated DNA.
F/HN-virosome-mediated gene transfer into 293 cells
Transformed human kidney cells (293 cell, 1 × 10 5 ) were seeded in 24-well plates and grown for 24 h at 37 o C. The cells were washed once with a serum-free media. The F/HN-virosomes that contained 5 µg DNA of the luciferase gene were then added to the cells in the serum-free medium. The serum-free medium was replaced by a serum-containing medium 2 h later, and the cells were incubated for an additional 24 h. The transfected cells were then lysed with a 100 µl lysis buffer (0.05% Triton X-100, 2 mM EDTA, 0.1 M Tris-HCl, pH 7.8). The luciferase activity of the cell lysates was measured with the luciferase assay system (Promega, Madison, USA) in a luminometer (MultiLumat LB9506, BG&G Berthold, Bad Wildbad, Germany). The protein concentrations of the cell lysates were determined by a standard protein assay (Bio-Rad, Hercules, USA). The luciferase activity of each sample was expressed as relative light units (RLU) per microgram of the extracted total proteins.
Results and Discussion
Characterization of F/HN proteins and virosomes In this study, three different types of Sendai virosomes, reconstituted Sendai fusogenic membrane proteins in liposomal membranes, were prepared by changing the liposomal lipid formulations and their in vitro gene-transfer capability compared. In order to reconstitute the viral membrane proteins quantitatively, the F and HN proteins were purified from the Sendai virus by a detergent lysis and sequential centrifugation procedure. A SDS-PAGE analysis of the purified protein mixture revealed relatively pure bands that corresponded to the F protein (45 kDa) and HN proteins (66 kDa) (Fig. 1) .
Several different formulations of Sendai virosomes have been described, depending on their application purposes. The first of these was exclusively prepared with endogenous Sendai viral lipids (Bagai and Sarkar, 1994) . Due to the considerable amount of viral lipids that were used during the reconstitution process and the low encapsulation capacity, this type of virosome was not considered an efficient system for drug or gene delivery. In order to overcome these problems, a certain amount of exogenous lipids (including cholesterol) was added during the reconstitution of the F/HN proteins in the production of virosomes. The composition and ratio of the lipids that were added to the virosomes originated from ones that were found in animal cell membranes and the envelopes of RNA viruses, such as the HIV and Sendai viruses (Ponimaskin et al., 2000) . Another type of Sendai virosome (called HVJ-liposomes) was prepared by incubation of inactivated Sendai virus with liposome-encapsulated DNA. For clinical application, this type of virosome suffered serious drawbacks, including virus contamination. Recently, HVJliposomes were prepared by the reconstitution of viral particles in a manner that would assist in overcoming the virus contamination (Kaneda et al., 1999) .
Sendai virosomes are spontaneously formed during the dialysis of components that are completely dispersed in an octylglucoside (OG) detergent solution. In the present work, the formation of the Sendai virosome vesicles by detergent dialysis was observed by electron microscopy after negative staining (Fig. 2) . Three different formulations of the Sendai virosomes were prepared with quantitatively-measured F/HN proteins. The first of these were ASVE (artificial Sendai viral envelope)-virosomes, whose lipid composition was derived 
Fig. 2. Electron microscopic appearance of Sendai virosomes. Electron-microscopic photographs of ASVE-virosomes (A), PSvirosomes (B)
, and PA-virosomes (C) (100 : 1, lipid wt/protein wt) were taken after negative staining with 5% uranyl acetate. The bars represent 100 nm.
from that of the endogenous Sendai viral lipids (Sechoy et al., 1986) . As described earlier, the ASVE-virosome lipids consist of phospholipids (PA, PE, PS, PC, and SM) and cholesterol in a 1:0,8, molar ratio. Two other virosomes (PS-and PAvirosomes) were prepared with PC/Chol/PS or PC/Chol/PA in a 4.8:2:1 molar ratio. All of the formulations were able to spontaneously form stable virosomal vesicles on detergent dialysis.
In vitro gene transfer mediated by F/HN-virosomes of varied lipid compositions
In order to examine the genetransfer capabilities of three different types of F/HN virosomes (ASVE-, PS-, and PA-virosomes), 293 cells were treated for 2 h with the luciferase gene that contained virosomes of these types. Under the experimental conditions, the transfection efficiency of the ASVE-virosomes was higher than that of the other formulations, as well as that of the DOTAP-based cationic liposomes, the leading type of cationic liposomes that are utilized for an in vitro gene transfer (Fig.  3) . Interestingly, the PS-virosomes exhibited better gene transfection than the PA-virosomes.
The pattern of gene-transfer efficiency of the various virosome types became clearer by changing the concentration of the added DNA. Gene transfer that was mediated by ASVE-and PS-virosomes was gradually enhanced by the incorporation of increasing the DNA amounts (Fig. 4) . The ASVE-virosomes exhibited the highest gene expression at DNA concentrations that exceeded 1.25 µg DNA per well. The PS-virosome gene transfers also increased with the DNA amount that was added. The transfers were lower than those of the ASVE-virosomes at the same DNA concentrations. Virosomes that contained PA were inefficient as gene-transfer vectors. On the other hand, the highest gene expression level that was mediated by cationic DOTAP-liposomes was attained with 1 µg DNA (Fig. 2 and Fig. 4) .
Generally, virosomal vesicles for delivery of therapeutic agents (including DNA) have been prepared with neutral or acidic lipids (Dzau et al., 1996; Ponimaskin et al., 2000) . Recently we also reported that negatively-charged PS that contained Sendai virosomes efficiently transfer genes into cultured cells (Kim and Park, 2002) . However, among the electron negatively-charged virosomes, the ASVE-and PSvirosomes were relatively efficient in gene transfer while the PA-virosomes were not (Fig. 3 and Fig. 4) . The order of genetransfer capacity among the virosomes that were prepared was PA-<<PS-<ASVE-virosomes. There is no clear explanation for the different gene-transfer capabilities between the PS-and PA-containing virosomes. It can only be speculated that the PA molecules may not provide a good environment for the fusogenic activity of the F/HN-proteins. PS and PA virosomes have different biophysical properties, including hydration density around the polar head-groups of the lipids in their lipid bilayers (Jendrasiak et al., 1996) . The hydration intensity that is provided by PS virosomes should yield a better aqueous microenvironment for the proper configuration of fusogenic F/ HN-proteins in the lipid bilayers than that provided by PA virosomes. These differences in hydration also affect lateral packing of the lipid bilayers, another primary factor that governs the interaction and fusion between membranes (Yang et al., 1997) . It has been reported that the infectivity of the RNA viruses (such as HIV and Sendai virus) is reduced with the reduction of the cholesterol content in the viral envelope (Citovsky et al., 1986; Aloria et al., 1988) , which indirectly supports this speculation. Among the three different virosome types, the ASVE-virosomes exhibited the best gene-transfer Fig. 3 . In vitro gene transfection mediated by various formulations of Sendai virosomes. The ASVE-, PS-, or PAvirosomes that were prepared with 5 µg DNA were added to 293 cells. The DOTAP lipoplex that contained 1 µg DNA was added to the cells for comparison. After transfection for 2 h and incubation for 24 h, the expression of the transfected gene was assayed by measuring the luciferase activity. Fig. 4 . Effect of the amount of virosomal DNA on the in vitro gene transfection. The ASVE-, PS-, or PA-virosomes that were prepared with various amounts of DNA were added to 293 cells. After the same transfection process that was previously described, the enzymatic activity of the expressed luciferase was assayed.
capability. It is logical that the virosomal membranes that mimic the Sendai envelopes would be very effective in membrane fusion, and that the ASVE-virosomes that contained DNA would have more potent gene-transfer capability when compared to the PS-and PA-virosomes. The fusogenic proteins that were reconstituted into the virosomes were another major factor that governed transfection efficiency. In this study, the F/HN-proteins were reconstituted at a 1 : 100 weight ratio of protein to lipid, the ratio at which in vitro gene transfection has been found to be the most efficient (Kim and Park, 2002) .
Gene transfection dependence on Ca 2+ concentration It has been reported that the membrane fusion that is mediated by the Sendai virus is dependent upon the extracellular Ca 2+ concentration (Al-Ahdal et al., 1986) . In order to investigate whether the gene transfer capability of the Sendai virosomes that were prepared for this study was indeed dependent upon the extracellular Ca 2+ concentration, 293 cells were treated with ASVE-, PS-, or PA-virosomes for 2 h at various Ca 2+ concentrations. The luciferase expression that was mediated by the ASVE-F/HN and PS-F/HN virosomes was significantly affected by the presence of Ca 2+ (Fig. 5) . The ASVE-and PS-virosomes were able to induce the highest gene expression at 10 mM and 5 mM Ca 2+ , respectively. Meanwhile, the gene transfer by PA-virosomes was substantially lower and only slightly affected by the Ca 2+ concentration. The virosome-mediated gene transfection required at least a physiological Ca 2+ concentration (2 mM).
Calcium ion concentration is one of the crucial parameters that govern biophysical properties of lipid bilayers, as well as the biochemical functions of receptor molecules on cell surfaces (Aliza and Abraham, 1972) . It is claimed that the Ca 2+ role in the interaction of pure phospholipid vesicles with cell surfaces can be attributed to an increase in surface tension, which results in the binding of the vesicle to the surface, followed by fusion (Al-Ahdal et al., 1986) . This Ca 2+ -dependency could be an obstacle to further applications of virosomes to the in vivo gene transfer. The Ca 2+ concentration may be temporarily increased in the transfected areas after direct administration of virosomes into subcutaneous areas, muscle, or tumor tissues. However, for systemic transfection, it would be very difficult, and even dangerous, to increase the Ca 2+ concentration beyond the physiological range. Therefore, in order for the Sendai F/HN-virosomes to be utilized for systemic applications, virosomal formulations will require further improvement to overcome the transfection-related Ca 2+ -dependency. Another major parameter that affects gene-transfer efficiency is the amount of plasmid DNA that can be encapsulated in the virosomes. Only 5% of DNA that is added to the virosomal solutions was encapsulated during reconstitution of the F/HN-proteins (data not shown). This explains why a relatively higher amount of DNA (10 µg DNA/well) was required for the virosomes to reach their maximal gene expression when compared to DOTAP liposomes (1 µg DNA/well). Encapsulation of larger DNA amounts into virosomes should result in higher gene-transfer efficiency, and may also resolve the Ca 2+ -dependancy problem as well.
This study has suggested that the Sendai F/HN-virosomes can be effectively utilized, instead of cationic liposomes, as gene transfer vectors for in vitro genetic modification. These fusogenic virosomes may advantageously have the potential for tissue-specific targeting by conjugation of tissue-specific antibodies (or cell-specific ligands) to the virosome surface while cationic liposomes may not. Further research will be needed in order to realize the clinical potential of Sendai virosomes in gene therapy. 
